Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001554795-14-000625
Filing Date
2014-11-12
Accepted
2014-11-12 11:42:16
Documents
10
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q skin1107form10q.htm 10-Q 131784
2 EXHIBIT 31.1 skin1107form10qexh31_1.htm EX-31.1 8466
3 EXHIBIT 31.2 skin1107form10qexh31_2.htm EX-31.2 8508
4 EXHIBIT 32.1 skin1107form10qexh32_1.htm EX-32.1 4557
  Complete submission text file 0001554795-14-000625.txt   658585

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE skin-20140930.xml EX-101.INS 28673
6 XBRL SCHEMA FILE skin-20140930.xsd EX-101.SCH 6369
7 XBRL CALCULATION FILE skin-20140930_cal.xml EX-101.CAL 16865
8 XBRL DEFINITION FILE skin-20140930_def.xml EX-101.DEF 4598
9 XBRL LABEL FILE skin-20140930_lab.xml EX-101.LAB 59651
10 XBRL PRESENTATION FILE skin-20140930_pre.xml EX-101.PRE 40224
Mailing Address 2157 S. LINCOLN ST SALT LAKE CITY UT 84106
Business Address 2157 S. LINCOLN ST SALT LAKE CITY UT 84106 8013232395
SKINOVATION PHARMACEUTICAL INC (Filer) CIK: 0001118072 (see all company filings)

EIN.: 870458170 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30991 | Film No.: 141212448
SIC: 6770 Blank Checks